Dapasis 5mg Tablet
Marketer
Akesiss Pharma Pvt Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dapasis 5mg Tablet
GlucoReg 5mg tablets are indicated for monotherapy or combination therapy in managing type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular health. GlucoReg 5mg can be administered with or without food, consistently at the same time each day, as prescribed by your physician. Discontinuation should only occur under medical supervision; otherwise, hyperglycemia and potentially serious consequences such as renal impairment and vision loss may result. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, all guided by your doctor's recommendations. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Fluid loss may occur; increased hydration is advised to counter dehydration. Practicing good hygiene aids in preventing genital fungal infections. Prior to commencing treatment, disclose any existing kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel. Limit alcohol consumption, as this may heighten the incidence of side effects. Regular blood glucose monitoring is crucial during treatment.
Primary Ingredients of Dapasis 5mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Dapasis 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dapasis 5mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapasis 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Dapasis 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapasis 5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapasis 5mg Tablets can be consumed with or without food, although consistent daily timing is recommended.
How Dapasis 5mg Tablet works:
Dapasis 5mg tablets manage high blood sugar by increasing urinary sugar excretion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Dapasis 5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapasis 5mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapasis 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Dapasis 5mg Tablets is contraindicated in individuals with renal impairment and should be omitted. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapasis 5mg tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Dapasis 5mg Tablet :
Should you forget to take your Dapasis 5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Dapasis 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently